SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-082149
Filing Date
2023-03-28
Accepted
2023-03-28 16:07:02
Documents
12
Period of Report
2023-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d492554d8ka.htm   iXBRL 8-K/A 22546
  Complete submission text file 0001193125-23-082149.txt   149470

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aadi-20230302.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20230302_lab.xml EX-101.LAB 18702
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20230302_pre.xml EX-101.PRE 11690
6 EXTRACTED XBRL INSTANCE DOCUMENT d492554d8ka_htm.xml XML 4217
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38560 | Film No.: 23769569
SIC: 2834 Pharmaceutical Preparations